Sex differences in outcomes of disease-modifying treatments for multiple sclerosis: A systematic review.

Author: HuXueqiang, LiRui, LuZhengqi, MaoZhifeng, QiuWei, ShuYaqing, SunXiaobo, XiaoLi

Paper Details 
Original Abstract of the Article :
Multiple sclerosis (MS) is a chronic immune mediated demyelinating disease of the central nervous system that exhibits sexual dimorphism and may benefit from sex-specific treatment. To investigate a potential influence of sex on immunomodulatory therapeutic effects in patients with MS, we performed ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1016/j.msard.2017.01.001

データ提供:米国国立医学図書館(NLM)

Multiple Sclerosis Treatment: Tailoring Therapy to Sex

Multiple sclerosis (MS), a debilitating autoimmune disease, exhibits [sexual dimorphism] in its presentation and progression. This study investigates the potential for [sex-specific treatment] in MS by reviewing the existing literature on the effects of disease-modifying treatments (DMTs) on men and women. The authors explore the evidence for [sex differences in treatment responses], aiming to identify potential areas for personalized treatment approaches in MS.

The Desert of MS Treatment: Finding the Right Path for Each Individual

The study found that there is evidence for [sex differences in outcomes] of DMTs in MS. These findings underscore the importance of considering sex as a factor in [treatment selection and monitoring] for MS patients.

Personalized Medicine: The Future of MS Treatment

This research highlights the growing importance of [personalized medicine] in managing complex diseases like MS. By considering individual factors like sex, genetics, and disease course, healthcare professionals can tailor treatment plans to improve outcomes for patients.

Dr.Camel's Conclusion

The desert of MS research is vast and complex, but we are continually discovering new pathways to better treatments. This study reminds us that understanding individual differences is crucial for providing effective and personalized care for patients with MS.

Date :
  1. Date Completed 2017-03-20
  2. Date Revised 2018-12-02
Further Info :

Pubmed ID

28283101

DOI: Digital Object Identifier

10.1016/j.msard.2017.01.001

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.